Squarex

Growth Stage

Preventing oral herpes with a topical application to the arm

Analytics

Raised to Date: Raised: $94,662

Aggregate Commitments $

Platform

Wefunder

Start Date

09/14/2021

Close Date

04/30/2022

Min. Goal

$50,000

Max. Goal

$1,070,000

Min. Investment

$100

Security Type

SAFE

Funding Type

RegCF

Valuation Cap

$99,100,000

Discount Rate

0%

Rolling Commitments $

Status

Active

Reporting Date

09/19/2021

Days Remaining

223

% of Min. Goal

189%

% of Max. Goal

9%

Likelihood of Max
extremely
Avg. Daily Raise

$18,932

Momentum
hot
Log in or create a free account today to gain access to KingsCrowd analytics.
Location

Saint Paul, Minnesota

Industry

Healthcare & Pharmaceuticals

Tech Sector

Biotech

Squarex, with a valuation of $99.1 million, is raising funds on Wefunder. The company is working on developing the prevention of oral herpes using a topical application to the arm. A single topical application to the arm will be enough to prevent outbreaks for over four months. Squarex’s drug has completed Phase 2 clinical trials and is on the path to commercialization. Hugh McTavish and Thomas D. Horn founded Squarex in June 2012. The current crowdfunding campaign has a minimum target of $50,000 and a maximum target of $1,070,000. The campaign proceeds will be used for rent, debt repayment, testing, clinical trial, and drug manufacturing.
Log in or create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Starter

$8.33 /month
billed annually
Free portfolio tracking. Limited reports and filters.
Plan Includes:
Everything in Free, plus
Advanced company search ( limited filters)
Founder profiles and exclusive webinars
2 Analyst Reports per month
Get Starter Annual

Pro

$25 /month
billed annually
Unlimited analyst reports and market analytics.
Plan Includes:
Everything in Starter, plus
Full access to all Analyst Reports
Filter on Staff Picks (e.g. Top Deal, Deal to Watch, etc.)
Market Analytics
Get Pro Annual

Merlin

$41.67 /month
billed annually
Full site access including Merlin ratings.
Plan Includes:
Everything in Pro, plus
Search and filter companies by Merlin ratings
Company specific Merlin rating and risk assessment
Get Merlin Annual
Already a member? Log in here.

Analyst Report

Other Deals

Covira Surgical on StartEngine 2021

The biotech company is focused on novel therapeutic alternatives to reduce post-surgical infections. The procedures of Covira Surgical leverage the…

Valuation: $9,987,500
Min Investment: $250
Industry: Healthcare & Pharmaceuticals
Raised $185,816 of $1,070,000 max
RegCF

Fluo Labs on StartEngine 2021

The medical device of Fluo Labs uses light therapy to relieve patients of their allergy symptoms without the use of…

Valuation: $12,000,000
Min Investment: $250
Industry: Healthcare & Pharmaceuticals
Raised $85,021 of $3,800,000 max
RegCF

Actipulse Neuroscience on Republic 2021

The business also aims to bring non-invasive treatment to patients’ homes. Adrien Chatillon founded Actipulse Neuroscience in June 2019. The…

Valuation Cap: $10,000,000
Min Investment: $100
Industry: Healthcare & Pharmaceuticals
Raised $92,426 of $1,070,000 max
RegCF

Create your first portfolio

Create your very own investment portfolio on KingsCrowd.

Now you can track all of your startup investments in one place utilizing our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
Add Squarex on Wefunder 2021

Follow company

Follow Squarex on Wefunder 2021